INSULIFE LLC

Insulife LLC specializes in basic insulin syringes and needles. These devices are designed for single-use subcutaneous insulin administration, commonly used in diabetes management. The products are intended to provide patients with a convenient way to inject insulin, often featuring pre-filled or disposable components.

Insulife LLC is based in the United States. Since the company operates within the U.S., its devices must comply with FDA regulations, including those for insulin delivery systems. The location ensures alignment with domestic regulatory requirements, such as UDI listing and classification standards.

Insulife LLC’s devices fall under FDA Class II regulatory classification. This classification is assigned based on the risk level of the product—Class II devices generally pose moderate risks and require special controls beyond general good manufacturing practices to ensure safety and effectiveness. The classification influences labeling requirements, post-market surveillance, and compliance obligations.

Yes, Insulife LLC’s devices are listed in the FDA’s Unique Device Identification (UDI) database. UDI listing ensures traceability and transparency in the supply chain, allowing healthcare providers, regulators, and patients to verify device authenticity, recall history, and compliance status. This helps streamline tracking and reduces risks associated with counterfeit or mislabeled products.